INmune Bio’s XPro1595 Prevents Brain-Injury-Induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-Reviewed Preclinical Study
INmune Bio announced peer-reviewed preclinical data demonstrating that XPro1595, their lead neuroinflammation drug candidate, selectively neutralizes soluble TNF and prevents brain-injury-induced amyloid pathology, cognitive deficits, and pain in an Alzheimer's disease mouse model. These findings, funded by the Department of Defense, elucidate the …